SCHEMBL5037396

SCHEMBL5037396

CC(=O)Nc1cccc(CC(N)=O)c1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.57
AOC3 Q16853 1/20 0.57
NPSR1 Q6W5P4 1/20 0.55
HSD17B10 Q99714 2/20 0.54
CYP1A2 P05177 1/20 0.54
RAB9A P51151 2/20 0.54
POLB P06746 1/20 0.54
NR4A1 P22736 1/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
MEN1 O00255 1/20 0.52
TSHR P16473 1/20 0.52
KMT2A Q03164 1/20 0.52
CSNK2A1 P68400 1/20 0.52
NLRP3 Q96P20 1/20 0.51
SIRT2 Q8IXJ6 1/20 0.51
SIRT3 Q9NTG7 1/20 0.51
MAPT P10636 1/20 0.49
NAPRT Q6XQN6 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11627789 0.86 CSNK2A1 (0.54) AOC3KMT2ACSNK2A1MAPT
SCHEMBL10391003 0.86 ALDH1A1 (0.58) ALDH1A1AOC3NPSR1HSD17B10CYP1A2
SCHEMBL3976944 0.85 NR1H4 (0.61) ALDH1A1NPSR1HSD17B10CYP1A2RAB9A
SCHEMBL875279 0.84 AOC3 (0.55) ALDH1A1AOC3NPSR1HSD17B10CYP1A2
SCHEMBL843452 0.84 AOC3 (0.55) ALDH1A1AOC3NPSR1HSD17B10CYP1A2
SCHEMBL14148255 0.83 CSNK2A1 (0.48) ALDH1A1AOC3POLBKMT2ACSNK2A1
SCHEMBL2545099 0.83 ALDH1A1 (0.61) ALDH1A1AOC3NPSR1HSD17B10CYP1A2
SCHEMBL17653723 0.82 SLC7A5 (0.55) ALDH1A1AOC3NPSR1HSD17B10CYP1A2
SCHEMBL30489996 0.82 SLC7A5 (0.55) ALDH1A1AOC3NPSR1HSD17B10CYP1A2
SCHEMBL15006319 0.82 NPSR1 (0.54) ALDH1A1AOC3NPSR1HSD17B10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104936954-A compounds and methods of use thereof AGIOS PHARMACEUTICALS INC 2015-09-23 CN disclosed
EP-1450796-B1 BENZOTHIAZOLE DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-04-09 EP disclosed
US-6596718-B1 A compound of formula I has a good affinity to the A2A receptor and is useful for the treatment of diseases mediated by this receptor. HOFFMANN-LA ROCHE INC. 2003-07-22 US disclosed